Page 60 - 81_02

4. Wagenseil JE, Mecham RP. Vascular Extracellular
Matrix and Arterial Mechanics. Physiol Rev 2009; 89:
957-89.
5. Midwood KS, Orend G. The role of tenascin-C in
tissue injury and tumorigenesis. J Cell Commun
Signal 2009; 3: 287-310.
6. Gibbons GH, Dzau VJ. The emerging concept of
vascular remodeling. N Engl J Med 1994; 330: 1431-
8.
7. Renna NF, de las Heras N, Miatello RM.
Pathophysiology of Vascular Remodeling in
Hypertension. Int J Hypertens 2013; 2013: 808353.
8. Mulvany MJ. Vascular remodelling of resistance
vessels: Can we define this?. Cardiovasc Res 1999;
41: 9-13.
9. Schiffrin EL. Vascular remodeling in hypertension:
mechanisms and treatment. Hypertension 2012; 59:
367-74.
10. Intengan HD, Schiffrin EL. Vascular remodeling in
hypertension: Roles of apoptosis, inflammation, and
fibrosis. Hypertension 2001; 38: 581-7.
11. Nørrelund H, Christensen KL, Samani NJ, Kimber P,
Mulvany MJ, Korsgaard N. Early narrowed afferent
arteriole is a contributor to the development of
hypertension. Hypertension 1994; 24: 301-8.
12. Briones AM, Xavier FE, Arribas SM, González MC,
Rossoni LV, Alonso MJ, Salaices M. Alterations in
structure and mechanics of resistance arteries from
ouabain-induced hypertensive rats. Am J Physiol
Heart Circ Physiol 2006, 291: H193-201.
13. Chandesris MO, Azarine A, Ong KT, Taleb S,
Boutouyrie P, Mousseaux E, Romain M, Bozec E,
Laurent S, Boddaert N, Thumerelle C, Tillie-Leblond
I, Hoarau C, Lebranchu Y, Aladjidi N, Tron F,
Barlogis V, Body G, Munzer M, Jaussaud R, Suarez
F, Clément O, Hermine O, Tedgui A, Lortholary O,
Picard C, Mallat Z, Fischer A. Frequent and
widespread vascular abnormalities in human signal
transducer and activator of transcription 3 deficiency.
Circ Cardiovasc Genet 2012; 5: 25-34.
14. Heagerty AM, Aalkjaaer C, Bund SJ, Korsgaard N,
Mulvany MJ. Small artery tructure in hypertension.
Dual process of remodeling and growth. Hypertension
1993; 21: 391-7.
15. Rizzoni D, Agabiti-Rosei E. Structural abnormalities
of small resistance arteries in essential hypertension. 29. Bush E, Maeda N, Kuziel WA, Dawson TC, Wilcox
Intern Emerg Med 2012; 7: 205-12.
16. Bakker EN, van der Meulen ET, van den Berg BM,
Everts V, Spaan JA, VanBavel E. Inward remodeling
follows chronic vasoconstriction in isolated resistance
arteries. J Vasc Res 2002; 39: 12-20.
17. Rizzoni D, Porteri E, Boari GE, De Ciuceis C,
Sleiman I, Muiesan ML, Castellano M, Miclini M,
Agabiti-Rosei E. Prognostic significance of
smallartery structure in hypertension. Circulation
2003; 108: 2230-5.
18. Mathiassen ON, Buus NH, Sihm I, Thybo NK, Mørn
B, Schroeder AP, Thygesen K, Aalkjaer C, Lederballe
O, Mulvany MJ, Christensen KL. Small artery
140
Andrea Aguado et al.
structure is an independent predictor of cardiovascular
events in essential hypertension. J Hypertens 2007;
25: 1021-6.
19. Moore WS. Vascular and Endovascular Surgery: A
Comprehensive Review. Available from: http://www.
www.inkling.com/read. Accessed: 16th September
2014.
20. van Varik BJ, Rennenberg RJ, Reutelingsperger CP,
Kroon AA, de Leeuw PW, Schurgers LJ. Mechanisms
of arterial remodeling: lessons from genetic diseases.
Front Genet 2012; 3: 290.
21. Newby AC. Matrix metalloproteinases regulate
migration, proliferation, and death of vascular smooth
muscle cells by degrading matrix and non-matrix
substrates. Cardiovasc Res 2006; 69: 614-24.
22. Kumar A, Lindner V. Remodeling with neointima
formation in the mouse carotid artery after cessation
of blood flow. Arterioscler Thromb Vasc Biol 1997;
17:2238-44.
23. Kawasaki T, Dewerchin M, Lijnen HR, Vreys I,
Vermylen J, Hoylaerts MF. Mouse carotid artery
ligation induces platelet-leukocyte-dependent luminal
fibrin, required for neointima development. Circ Res
2001; 88: 159-66.
24. Roque FR, Briones AM, García-Redondo AB, Galán
M, Martínez-Revelles S, Avendaño MS, Cachofeiro
V, Fernandes T, Vassallo DV, Oliveira EM, Salaices
M. Aerobic exercise reduces oxidative stress and
improves vascular changes of small mesenteric and
coronary arteries in hypertension. Br J Pharmacol
2013; 168: 686-703.
25. Xu S, Touyz RM. Reactive oxygen species and
vascular remodeling in hypertension: still alive.
Canadian Journal of Cardiology 2006; 22: 947-51.
26. Valente AJ, Yoshida T, Murthy SN, Sakamuri SS,
Katsuyama M, Clark RA, Delafontaine P,
Chandrasekar B. Angiotensin II enhances AT1-Nox1
binding and stimulates arterial smooth muscle cell
migration and proliferation through AT1, Nox1, and
interleukin-18. Am J Physiol Heart Circ Physiol 2012;
303: H282-96.
27. Ozasa Y, Akazawa H, Qin Y, Tateno K, Ito K, Kudo-
Sakamoto Y, Yano M, Yabumoto C, Naito AT, Oka
T, Lee JK, Minamino T, Nagai T, Kobayashi Y,
Komuro I. Notch activation mediates angiotensin II-
induced vascular remodeling by promoting the
proliferation and migration of vascular smooth muscle
cells. Hypertens Res 2013; 36: 859-65.
28. Chiou WF, Chen CC, Wei BL. 3,4-Di-O-
Caffeoylquinic Acid Inhibits Angiotensin-II-Induced
Vascular Smooth Muscle Cell Proliferation and
Migration by Downregulating the JNK and PI3K/Akt
Signaling Pathways. Evid Based Complement
Alternat Med 2011; 2011: 634502.
JN, DeLeon H, Taylor WR.CC. chemokine receptor 2
is required for macrophage infiltration and vascular
hypertrophy in angiotensin II-induced hypertension.
Hypertension 2000; 36: 360-3.
@Real Academia Nacional de Farmacia. Spain